ChemicalBook > Product Catalog >Pharmaceutical intermediates >Heterocyclic compound >Pyridine compound >Ethylpyridine >GSK1904529A

GSK1904529A

GSK1904529A Structure
CAS No.
1089283-49-7
Chemical Name:
GSK1904529A
Synonyms
CS-29;GSK 4529;GSK1904529A;GSK1904529A, >=98%;GSK1904529A (GSK-4529;IGF-IR, IGF-IIR inhibitor;IGF-1R inhibitor GS1904529A;GSK1904529A ISO 9001:2015 REACH;GSK1904529A;GSK-1904529A;GSK 1904529A;GSK1904529A : IGF-IR, IGF-IIR inhibitor
CBNumber:
CB92501005
Molecular Formula:
C44H47F2N9O5S
Molecular Weight:
851.96
MOL File:
1089283-49-7.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:41

GSK1904529A Properties

Density 1.39
storage temp. Store at -20°C
solubility ≥42.6 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
form solid
pka 11.12±0.70(Predicted)
color Light yellow to yellow

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
NFPA 704
0
2 0

GSK1904529A Chemical Properties,Uses,Production

Uses

A selective inhibitor of IGF-1R and IR with IC50s of 27 nM and 25 nM, respectively.

Global( 108)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
Shaanxi Dideu Medichem Co. Ltd +86-029-89586680 +86-18192503167 China 8853 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6393 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 United States 19973 58 Inquiry
Jilin Chinese Academy of Sciences-yanshen Technology +undefined18143011203 China 42057 58 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 57511 58 Inquiry

GSK1904529A Spectrum

1089283-49-7(GSK1904529A)Related Search:

GSK 4529 GSK1904529A GSK1904529A : IGF-IR, IGF-IIR inhibitor N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A GSK1904529A, >=98% IGF-IR, IGF-IIR inhibitor N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl] CS-29 GSK1904529A;GSK-1904529A;GSK 1904529A Benzamide, N-(2,6-difluorophenyl)-5-[3-[2-[[5-ethyl-2-methoxy-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-methoxy- GSK1904529A ISO 9001:2015 REACH GSK1904529A (GSK-4529 N-(2,6-Difluorophenyl)-5-(3-(2-((5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide IGF-1R inhibitor GS1904529A 1089283-49-7 C44H47F2N9O5S Inhibitors